Please wait
GE HealthCare Technologies Inc. (GEHC) is listed on NMS in the Healthcare sector, with exposure to Medical Devices. This page brings together the current share price, valuation, dividend context, business summary, and a practical current view so you can assess the stock faster.
Healthcare
₦41.3T
23.0%
14.85
Current price
₦90,870.00
Updated Updated just now
Conviction
75/100
Confidence
Low
Market tone
neutral · 75/100
Entry
Medium · 75/100
Recent price action for GEHC, so the page starts with the stock itself before the deeper analysis.
At least one liquidity signal is strong now, though large orders should still be staged.
Valuation view
Looks relatively cheap vs peers
Income view
Strong income profile
Market tone
neutral (75/100) — price action, attention, and recent context all lean here.
Entry view
Medium (75/100) — The company is profitable on the latest reported numbers.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Investors usually follow GEHC for its dividend profile, valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Official filings
0
Financial reports and company disclosures captured by Eye.
Market events
0
Insider, filing, dividend, and price events.
Source records
4
Captured updates we can trace.
Whisone is bullish because fundamentals are solid at 75/100 while price action is down 7.1%. Whisone has high conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
ROE
19.5%
Return on equity
ROA
5.2%
Return on assets
Debt / equity
0.99
Lower is usually safer.
P/B ratio
2.58
Useful for book value support.
Dividend yield
23.0%
Current income signal.
85/100
Direction
Cautious
Main supports
Business quality and balance-sheet strength are supporting the outlook.
Valuation still leaves room versus fair value and analyst anchors.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Execution risk and market swings can still delay the forecast playing out.
Fair value
₦104,940.00
Analyst view
Buy
Analyst target
₦119,000.00
Forecast refresh
Updated just now
Quality score
74
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
₦60.00
2025-01-14
Payment: TBA | Qualification: 2025-01-14 | Yield at declaration: N/A
₦45.00
2024-10-18
Payment: TBA | Qualification: 2024-10-18 | Yield at declaration: N/A
Yahoo Finance fundamentals snapshot
Updated 1d ago
US fundamentals synchronized from Yahoo Finance via yfinance.
US stock catalog seed
Updated 1d ago
Seeded from the built-in US stock catalog for database discovery and later background refresh.
Price points saved
250
Latest market date
2026-07-23
GEHC
GE HealthCare Technologies Inc.
Price: ₦90,870.00
P/E: 14.84804
Yield: 23.0%
ABBV
AbbVie Inc.
Price: ₦389,040.00
P/E: 127.76354
Yield: 2.7%
ABT
Abbott Laboratories
Price: ₦154,590.00
P/E: 33.352753
Yield: 2.5%
ALGN
Align Technology, Inc.
Price: ₦250,522.50
P/E: 28.248322
Yield: 0.0%
Industry
Medical Devices
Employees
54000
Exchange
NMS
Ticker
GEHC
